|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 19739472.9 (espacenet) (Federated) (European Patent Register), 20190620 | | Patent/reg. no. and date | DK/EP 3810281, 20240724 | | Publication date | 20210428 | | Priority no. and date | US 201862688251 P, 20180621 | | EP pub. no. and date |
EP 3810281 20210428 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V479556DK00 | | Inventor | CRAWFORD, Alison, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , A61K 39/00 (2006.01) | | Title | Fremgangsmåder til behandling af cancer med bispecifikke antI-CD3XMUC16-antistoffer og anti-PD-1-antistoffer | | Int. application no. | US2019038163 | | Int. publication no. | WO2019246356 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
